3/23/20: In a March 22 article posted on the National Law Review, authors Scott F. Roybal and Matthew T. Lin from Sheppard, Mullin, Richter & Hampton LLP, cautions companies to beware of the risks for false claims as relief funds are readied to flow...
They highlight six “potential FCA pitfalls when responding to COVID-19.” Among them: billing to Medicare or Medicaid; selling substandard products to the government; and making false certifications of compliance with payment and relief fund requirements. Fortunately, the authors also provide guidance on avoiding FCA liability. They have written a good, useful article...